Cargando…

Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis

INTRODUCTION: Osteoporosis represents the second most common cause of endocrinopathy in patients with beta thalassemia major (BTM). Some drugs proved effective to reduce vertebral and non-vertebral fracture risk. Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear fac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yassin, Mohamed A., Soliman, Ashraf T., De Sanctis, Vincenzo, Abdelrahman, Mohamed Osman, Aziz Bedair, Elsaid M., AbdelGawad, Manal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138914/ https://www.ncbi.nlm.nih.gov/pubmed/25143915 http://dx.doi.org/10.4103/2230-8210.137516

Ejemplares similares

Growth hormone – insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major
por: Soliman, Ashraf, et al.
Publicado: (2014)

Vitamin D Status in Thalassemia Major: an Update
por: Soliman, Ashraf, et al.
Publicado: (2013)

Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines
por: De Sanctis, Vincenzo, et al.
Publicado: (2013)

Insulin-like growth factor- I and factors affecting it in thalassemia major
por: Soliman, Ashraf T., et al.
Publicado: (2015)

Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis
por: Yassin, Mohamed A., et al.
Publicado: (2020)

Radiological manifestation of avascular necrosis (AVN) in sickle cell disease (SCD): a review of diagnostic imaging
por: Mohamed Aziz Bedair, Elsaid, et al.
Publicado: (2023)

Cortisol response to low dose versus standard dose (back-to-back) adrenocorticotrophic stimulation tests in children and young adults with thalassemia major
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Nutritional studies in patients with β-thalassemia major: A short review
por: Soliman, Ashraf, et al.
Publicado: (2023)

Proposed Scoring System for Evaluating Clinico-radiological Severity of COVID- 19 using Plain Chest X- ray (CXR) changes (CO X-RADS): Preliminary results
por: Bedair, Elsaid M.A, et al.
Publicado: (2020)

Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC
por: Soliman, Ashraf T, et al.
Publicado: (2018)

Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment
por: De Sanctis, Vincenzo, et al.
Publicado: (2018)

Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content
por: Yassin, Mohamed A., et al.
Publicado: (2019)

Spontaneous iliopsoas hematoma in a trasfusion dependent β-thalassemia patient with hypersplenism: a case report
por: Aishwariya, Padmakumari, et al.
Publicado: (2019)

The effects of excess weight on glucose homeostasis in young adult females with β-thalassemia major (β-TM): A preliminary retrospective study
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Quality of life among adolescents aged 14 to 18 years with beta-thalassemia major (TM) in Qatar
por: Nashwan, Abdulqadir J., et al.
Publicado: (2018)

Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy
por: Soliman, Ashraf, et al.
Publicado: (2014)

Longitudinal study on thyroid function in patients with thalassemia major: High incidence of central hypothyroidism by 18 years
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Spinal cord compression secondary to extramedullary hematopoiesis: a rareness in a young adult with thalassemia major
por: Fareed, Shehab, et al.
Publicado: (2017)

Evolution of combined impaired fasting glucose and impaired glucose tolerance in β-thalassemia major: Results in 58 patients with a mean 7.7- year follow-up
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation
por: Ahmed, Shayma, et al.
Publicado: (2022)

Applications of Artificial Intelligence in Thalassemia: A Comprehensive Review
por: Ferih, Khaled, et al.
Publicado: (2023)

Osteoporosis in Iraqi patients with thalassemia
por: AL Jadir, Salim M, et al.
Publicado: (2012)

A persistent cough as atypical clinical presentation of intrathoracic extramedullary hematopoiesis (EMH) in a female with thalassemia intermedia
por: Abdulla, Mohammad AJ, et al.
Publicado: (2018)

Insulin-like growth factor -1 (IGF-1) and glucose dysregulation in young adult patients with β-thalassemia major: causality or potential link?
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications
por: Kanbour, Ibrahim, et al.
Publicado: (2018)

The recommendation of the International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine for the assessment of growth hormone secretion in thalassemia
por: De Sanctis, Vincenzo, et al.
Publicado: (2015)

Statural growth and prevalence of endocrinopathies in relation to liver iron content (LIC) in adult patients with beta thalassemia major (BTM) and sickle cell disease (SCD)
por: Yassin, Mohamed A, et al.
Publicado: (2018)

β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint
por: De Sanctis, Vincenzo, et al.
Publicado: (2017)

Thyroid Disorders in Homozygous β-Thalassemia: Current Knowledge, Emerging Issues and Open Problems
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

Clinical characteristics, biochemical parameters and insulin response to oral glucose tolerance test (OGTT) in 25 transfusion dependent β-thalassemia (TDT) patients recently diagnosed with diabetes mellitus (DM)
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Clinical image report of acute Cholangitis in Beta‐thalassemia major
por: Rozi, Waail, et al.
Publicado: (2022)

Spinal cord compression due to extramedullary hematopoiesis in patient with Beta thalassemia major
por: Subahi, Eihab A., et al.
Publicado: (2020)

Intravenous iron replacement therapy in eugonadal males with iron-deficiency anemia: Effects on pituitary gonadal axis and sperm parameters; A pilot study
por: Soliman, Ashraf, et al.
Publicado: (2014)

Management of adolescent gynecomastia: an update
por: T Soliman, Ashraf, et al.
Publicado: (2017)

Iron deficiency anemia and glucose metabolism
por: T Soliman, Ashraf, et al.
Publicado: (2017)

The experience of a tertiary unit on the clinical phenotype and management of hypogonadism in female adolescents and young adults with transfusion dependent thalassemia
por: Vincenzo, De Sanctis, et al.
Publicado: (2019)

Current practice in treating adult female thalassemia major patients with hypogonadism: An International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine survey from Italy
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Growth and growth hormone - Insulin Like Growth Factor - I (GH-IGF-I) axis in chronic anemias
por: Ashraf, T. Soliman, et al.
Publicado: (2017)

First report of COVID‐19 reinfection in a patient with beta thalassemia major
por: Okar, Lina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b6m29fp55afq80s2ct73ivrtns